GAO: FDA fails to follow up on unproven drugs
Monday, October 26, 2009 - 03:28
in Health & Medicine
(AP) -- The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn't extend patients' lives, say congressional investigators.